category

Earnings Report

Nasdaq jumps 1%, Johnson & Johnson keeps Dow down

U.S. equity markets ended mixed after the U.S. Food and Drug Administration recommended Johnson & Johnson’s COVID-19 vaccine be paused amid blood-clotting concerns and consumer prices rose at the fastest pace in over eight years.

Nasdaq jumps 1.5%, S&P flirts with record

The Nasdaq and S&P 500 rallied Wednesday as details of President Biden’s $2 trillion infrastructure package were released on the final day of the first quarter.